| Dr Kirsten Erica Redborg, MD | |
|
3900 Capital Mall Dr Sw, Olympia, WA 98502-8654 | |
| (360) 706-6212 | |
| Not Available |
| Full Name | Dr Kirsten Erica Redborg |
|---|---|
| Gender | Female |
| Speciality | Anesthesiology |
| Experience | 20 Years |
| Location | 3900 Capital Mall Dr Sw, Olympia, Washington |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023105764 | NPI | - | NPPES |
| 1015383 | Medicaid | VT |
| Facility Name | Location | Facility Type |
|---|---|---|
| Capital Medical Center | Olympia, WA | Hospital |
| Peacehealth St John Medical Center | Longview, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Capital Medical Center Specialty Physicians Llc | 2567651771 | 71 |
| Peacehealth | 5890689293 | 182 |
News Archive
YM BioSciences Inc., today reported updated interim safety and efficacy results from the Phase I/II study of its JAK1/JAK2 inhibitor, CYT387, for the treatment of myelofibrosis.
BSD Medical Corporation today announced that a study titled "BSD2000 Deep Hyperthermia Combined with Chemotherapy of PT regimen in Patients with Non-small Cell Lung Cancer" has been published in the current issue of The Chinese Journal of Lung Cancer (February 2010;13(2):132–135) by Yang, Zhao, and Wang.
This holiday season, Ocean Nutrition Canada (ONC) is giving a gift with vision. ONC, the largest supplier of Omega-3 EPA/DHA ingredients in the world, is helping to reduce blindness and mortality amongst children in the developing world by donating five million doses of vitamin A to Vitamin Angels.
Chimerix, Inc., a pharmaceutical company developing orally-available antiviral therapeutics, today announced first-in-human Phase 1 clinical trial results for CMX157 demonstrating a favorable safety, tolerability and drug distribution profile.
Higher levels in blood of the protein clusterin, also known as apolipoprotein J, are significantly associated with the prevalence and severity of Alzheimer's disease, but not with the risk of onset of new disease, according to a study in the April 6 issue of JAMA.
› Verified 2 days ago
| Entity Name | Providence Health & Services Washington |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174744304 PECOS PAC ID: 6709782600 Enrollment ID: O20031211000028 |
News Archive
YM BioSciences Inc., today reported updated interim safety and efficacy results from the Phase I/II study of its JAK1/JAK2 inhibitor, CYT387, for the treatment of myelofibrosis.
BSD Medical Corporation today announced that a study titled "BSD2000 Deep Hyperthermia Combined with Chemotherapy of PT regimen in Patients with Non-small Cell Lung Cancer" has been published in the current issue of The Chinese Journal of Lung Cancer (February 2010;13(2):132–135) by Yang, Zhao, and Wang.
This holiday season, Ocean Nutrition Canada (ONC) is giving a gift with vision. ONC, the largest supplier of Omega-3 EPA/DHA ingredients in the world, is helping to reduce blindness and mortality amongst children in the developing world by donating five million doses of vitamin A to Vitamin Angels.
Chimerix, Inc., a pharmaceutical company developing orally-available antiviral therapeutics, today announced first-in-human Phase 1 clinical trial results for CMX157 demonstrating a favorable safety, tolerability and drug distribution profile.
Higher levels in blood of the protein clusterin, also known as apolipoprotein J, are significantly associated with the prevalence and severity of Alzheimer's disease, but not with the risk of onset of new disease, according to a study in the April 6 issue of JAMA.
› Verified 2 days ago
| Entity Name | Peacehealth |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720056187 PECOS PAC ID: 5890689293 Enrollment ID: O20040209000272 |
News Archive
YM BioSciences Inc., today reported updated interim safety and efficacy results from the Phase I/II study of its JAK1/JAK2 inhibitor, CYT387, for the treatment of myelofibrosis.
BSD Medical Corporation today announced that a study titled "BSD2000 Deep Hyperthermia Combined with Chemotherapy of PT regimen in Patients with Non-small Cell Lung Cancer" has been published in the current issue of The Chinese Journal of Lung Cancer (February 2010;13(2):132–135) by Yang, Zhao, and Wang.
This holiday season, Ocean Nutrition Canada (ONC) is giving a gift with vision. ONC, the largest supplier of Omega-3 EPA/DHA ingredients in the world, is helping to reduce blindness and mortality amongst children in the developing world by donating five million doses of vitamin A to Vitamin Angels.
Chimerix, Inc., a pharmaceutical company developing orally-available antiviral therapeutics, today announced first-in-human Phase 1 clinical trial results for CMX157 demonstrating a favorable safety, tolerability and drug distribution profile.
Higher levels in blood of the protein clusterin, also known as apolipoprotein J, are significantly associated with the prevalence and severity of Alzheimer's disease, but not with the risk of onset of new disease, according to a study in the April 6 issue of JAMA.
› Verified 2 days ago
| Entity Name | Providence Health & Services Washington |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376624981 PECOS PAC ID: 9234048323 Enrollment ID: O20040227000254 |
News Archive
YM BioSciences Inc., today reported updated interim safety and efficacy results from the Phase I/II study of its JAK1/JAK2 inhibitor, CYT387, for the treatment of myelofibrosis.
BSD Medical Corporation today announced that a study titled "BSD2000 Deep Hyperthermia Combined with Chemotherapy of PT regimen in Patients with Non-small Cell Lung Cancer" has been published in the current issue of The Chinese Journal of Lung Cancer (February 2010;13(2):132–135) by Yang, Zhao, and Wang.
This holiday season, Ocean Nutrition Canada (ONC) is giving a gift with vision. ONC, the largest supplier of Omega-3 EPA/DHA ingredients in the world, is helping to reduce blindness and mortality amongst children in the developing world by donating five million doses of vitamin A to Vitamin Angels.
Chimerix, Inc., a pharmaceutical company developing orally-available antiviral therapeutics, today announced first-in-human Phase 1 clinical trial results for CMX157 demonstrating a favorable safety, tolerability and drug distribution profile.
Higher levels in blood of the protein clusterin, also known as apolipoprotein J, are significantly associated with the prevalence and severity of Alzheimer's disease, but not with the risk of onset of new disease, according to a study in the April 6 issue of JAMA.
› Verified 2 days ago
| Entity Name | Washington Orthopaedic Center Inc Ps |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689787103 PECOS PAC ID: 5496643165 Enrollment ID: O20040308000977 |
News Archive
YM BioSciences Inc., today reported updated interim safety and efficacy results from the Phase I/II study of its JAK1/JAK2 inhibitor, CYT387, for the treatment of myelofibrosis.
BSD Medical Corporation today announced that a study titled "BSD2000 Deep Hyperthermia Combined with Chemotherapy of PT regimen in Patients with Non-small Cell Lung Cancer" has been published in the current issue of The Chinese Journal of Lung Cancer (February 2010;13(2):132–135) by Yang, Zhao, and Wang.
This holiday season, Ocean Nutrition Canada (ONC) is giving a gift with vision. ONC, the largest supplier of Omega-3 EPA/DHA ingredients in the world, is helping to reduce blindness and mortality amongst children in the developing world by donating five million doses of vitamin A to Vitamin Angels.
Chimerix, Inc., a pharmaceutical company developing orally-available antiviral therapeutics, today announced first-in-human Phase 1 clinical trial results for CMX157 demonstrating a favorable safety, tolerability and drug distribution profile.
Higher levels in blood of the protein clusterin, also known as apolipoprotein J, are significantly associated with the prevalence and severity of Alzheimer's disease, but not with the risk of onset of new disease, according to a study in the April 6 issue of JAMA.
› Verified 2 days ago
| Entity Name | Capital Medical Center Specialty Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760785281 PECOS PAC ID: 2567651771 Enrollment ID: O20110104000592 |
News Archive
YM BioSciences Inc., today reported updated interim safety and efficacy results from the Phase I/II study of its JAK1/JAK2 inhibitor, CYT387, for the treatment of myelofibrosis.
BSD Medical Corporation today announced that a study titled "BSD2000 Deep Hyperthermia Combined with Chemotherapy of PT regimen in Patients with Non-small Cell Lung Cancer" has been published in the current issue of The Chinese Journal of Lung Cancer (February 2010;13(2):132–135) by Yang, Zhao, and Wang.
This holiday season, Ocean Nutrition Canada (ONC) is giving a gift with vision. ONC, the largest supplier of Omega-3 EPA/DHA ingredients in the world, is helping to reduce blindness and mortality amongst children in the developing world by donating five million doses of vitamin A to Vitamin Angels.
Chimerix, Inc., a pharmaceutical company developing orally-available antiviral therapeutics, today announced first-in-human Phase 1 clinical trial results for CMX157 demonstrating a favorable safety, tolerability and drug distribution profile.
Higher levels in blood of the protein clusterin, also known as apolipoprotein J, are significantly associated with the prevalence and severity of Alzheimer's disease, but not with the risk of onset of new disease, according to a study in the April 6 issue of JAMA.
› Verified 2 days ago
| Entity Name | Anesthesia Associates Northwest Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548281751 PECOS PAC ID: 7618908484 Enrollment ID: O20161115001177 |
News Archive
YM BioSciences Inc., today reported updated interim safety and efficacy results from the Phase I/II study of its JAK1/JAK2 inhibitor, CYT387, for the treatment of myelofibrosis.
BSD Medical Corporation today announced that a study titled "BSD2000 Deep Hyperthermia Combined with Chemotherapy of PT regimen in Patients with Non-small Cell Lung Cancer" has been published in the current issue of The Chinese Journal of Lung Cancer (February 2010;13(2):132–135) by Yang, Zhao, and Wang.
This holiday season, Ocean Nutrition Canada (ONC) is giving a gift with vision. ONC, the largest supplier of Omega-3 EPA/DHA ingredients in the world, is helping to reduce blindness and mortality amongst children in the developing world by donating five million doses of vitamin A to Vitamin Angels.
Chimerix, Inc., a pharmaceutical company developing orally-available antiviral therapeutics, today announced first-in-human Phase 1 clinical trial results for CMX157 demonstrating a favorable safety, tolerability and drug distribution profile.
Higher levels in blood of the protein clusterin, also known as apolipoprotein J, are significantly associated with the prevalence and severity of Alzheimer's disease, but not with the risk of onset of new disease, according to a study in the April 6 issue of JAMA.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kirsten Erica Redborg, MD Po Box 5299, Ms: 1313-5-pco, Tacoma, WA 98415-0299 Ph: (253) 459-8009 | Dr Kirsten Erica Redborg, MD 3900 Capital Mall Dr Sw, Olympia, WA 98502-8654 Ph: (360) 706-6212 |
News Archive
YM BioSciences Inc., today reported updated interim safety and efficacy results from the Phase I/II study of its JAK1/JAK2 inhibitor, CYT387, for the treatment of myelofibrosis.
BSD Medical Corporation today announced that a study titled "BSD2000 Deep Hyperthermia Combined with Chemotherapy of PT regimen in Patients with Non-small Cell Lung Cancer" has been published in the current issue of The Chinese Journal of Lung Cancer (February 2010;13(2):132–135) by Yang, Zhao, and Wang.
This holiday season, Ocean Nutrition Canada (ONC) is giving a gift with vision. ONC, the largest supplier of Omega-3 EPA/DHA ingredients in the world, is helping to reduce blindness and mortality amongst children in the developing world by donating five million doses of vitamin A to Vitamin Angels.
Chimerix, Inc., a pharmaceutical company developing orally-available antiviral therapeutics, today announced first-in-human Phase 1 clinical trial results for CMX157 demonstrating a favorable safety, tolerability and drug distribution profile.
Higher levels in blood of the protein clusterin, also known as apolipoprotein J, are significantly associated with the prevalence and severity of Alzheimer's disease, but not with the risk of onset of new disease, according to a study in the April 6 issue of JAMA.
› Verified 2 days ago
Bryan D Wales, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 3624 Ensign Rd Ne, Ste B, Olympia, WA 98506 Phone: 360-493-6400 | |
Calvin Takchun Wong, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 3901 Capital Mall Dr Sw, Olympia, WA 98502 Phone: 425-407-1500 | |
Dr. Douglas Wayne Taylor, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 3901 Capital Mall Dr Sw Ste A, Olympia, WA 98502 Phone: 360-786-8990 Fax: 360-786-9010 | |
Mark C Brackebusch, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 3900 Capitol Mall Dr Sw, Olympia, WA 98502 Phone: 360-754-5858 | |
Nathan Swiss, DO Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 413 Lilly Rd Ne, Olympia, WA 98506 Phone: 360-491-9480 | |
Charles Richard Harding, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 3624 Ensign Rd Ne, Ste B, Olympia, WA 98506 Phone: 360-493-6400 |